BAETTIG; Urs
Patent Applications and Registrations
Patent applications and USPTO patent grants for BAETTIG; Urs.The latest application filed is for "pyridine and pyrazine derivative for the treatment of cf".
Company Profile
2.23.30
- BAETTIG; Urs - Reinach CH
- Baettig; Urs - Horsham GB
- Baettig; Urs - West Sussex GB
- Baettig; Urs - Sussex GB
Patent Activity
| Patent | Date |
|---|---|
| Pyridine and Pyrazine Derivative for the Treatment of CF App 20210228554 - BAETTIG; Urs ; et al. | 2021-07-29 |
| Pyridine and Pyrazine Derivative for the Treatment of CF App 20190262324 - BAETTIG; Urs ; et al. | 2019-08-29 |
| Autotaxin inhibitors Grant 10,183,025 - Beattie , et al. Ja | 2019-01-22 |
| Pyridine and pyrazine derivative for the treatment of CF Grant 10,117,858 - Baettig , et al. November 6, 2 | 2018-11-06 |
| Pyridine and pyrazine derivative for the treatment of CF Grant RE46,757 - Baettig , et al. March 20, 2 | 2018-03-20 |
| Autotaxin Inhibitors App 20180021345 - BEATTIE; David ; et al. | 2018-01-25 |
| Autotaxin inhibitors Grant 9,763,957 - Beattie , et al. September 19, 2 | 2017-09-19 |
| Pyridine and Pyrazine derivative for the Treatment of CF App 20170071919 - BAETTIG; Urs ; et al. | 2017-03-16 |
| Autotaxin Inhibitors App 20160184318 - BEATTIE; David ; et al. | 2016-06-30 |
| Autotaxin Inhibitors App 20160168119 - BAETTIG; Urs ; et al. | 2016-06-16 |
| Pyridine and pyrazine derivative for the treatment of CF Grant 9,365,552 - Baettig , et al. June 14, 2 | 2016-06-14 |
| Squaramide derivatives as CXCR2 antagonist Grant 9,115,087 - Baettig , et al. August 25, 2 | 2015-08-25 |
| Choline salt of an anti-inflammatory substituted cyclobutenedione compound Grant 9,018,261 - Ambarkhane , et al. April 28, 2 | 2015-04-28 |
| Pyridine and Pyrazine derivative for the Treatment of CF App 20150045364 - BAETTIG; Urs ; et al. | 2015-02-12 |
| Organic Compounds App 20140213594 - BAETTIG; Urs ; et al. | 2014-07-31 |
| Choline Salt Of An Anti-inflammatory Substituted Cyclobutenedione Compound App 20140206768 - Ambarkhane; Ameet Vijay ; et al. | 2014-07-24 |
| Pyridine and Pyrazine derivative for the Treatment of CF App 20140135329 - BAETTIG; Urs ; et al. | 2014-05-15 |
| Squaramide derivatives as CXCR2 antagonist Grant 8,722,925 - Baettig , et al. May 13, 2 | 2014-05-13 |
| Pyridine and pyrazine derivative for the treatment of CF Grant 8,476,269 - Baettig , et al. July 2, 2 | 2013-07-02 |
| Organic Compounds App 20130005735 - Baettig; Urs ; et al. | 2013-01-03 |
| Organic compounds Grant 8,343,966 - Adcock , et al. January 1, 2 | 2013-01-01 |
| Squaramide derivatives as CXCR2 antagonist Grant 8,329,754 - Baettig , et al. December 11, 2 | 2012-12-11 |
| Pyridine and Pyrazine Derivative for the Treatment of CF App 20120277232 - BAETTIG; Urs ; et al. | 2012-11-01 |
| Squaramide derivatives as CXCR2 antagonist Grant 8,288,588 - Baettig , et al. October 16, 2 | 2012-10-16 |
| Pyridine and pyrazine derivative for the treatment of CF Grant 8,247,436 - Baettig , et al. August 21, 2 | 2012-08-21 |
| Quinuclidine derivatives binding to mucarinic M3 receptors Grant 8,168,654 - Collingwood , et al. May 1, 2 | 2012-05-01 |
| Quinuclidine derivatives and their use as muscarinic M3 receptor antagonists Grant 8,084,463 - Press , et al. December 27, 2 | 2011-12-27 |
| Squaramide derivatives as CXCR2 antagonist App 20110251206 - Baettig; Urs ; et al. | 2011-10-13 |
| Squaramide Derivatives As Cxcr2 Antagonist App 20110251205 - Baettig; Urs ; et al. | 2011-10-13 |
| Pyridine and Pyrazine derivative for the Treatment of CF App 20110230483 - BAETTIG; Urs ; et al. | 2011-09-22 |
| Squaramide derivatives as CXCR2 antagonist Grant 7,989,497 - Baettig , et al. August 2, 2 | 2011-08-02 |
| Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor Grant 7,947,730 - Collingwood , et al. May 24, 2 | 2011-05-24 |
| Quinuclidine Derivatives And Their Use As Muscarinic M3 Receptor Antagonists App 20100168132 - Press; Neil John ; et al. | 2010-07-01 |
| Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists Grant 7,723,356 - Press , et al. May 25, 2 | 2010-05-25 |
| Organic compounds for the treatment of inflammatory or allergic conditions Grant 7,678,826 - Axford , et al. March 16, 2 | 2010-03-16 |
| Quinuclidine Derivatives Binding To Mucarinic M3 Receptors App 20100041887 - Collingwood; Stephen Paul ; et al. | 2010-02-18 |
| Organic Compounds App 20100029670 - Baettig; Urs ; et al. | 2010-02-04 |
| Organic compounds App 20090215776 - Adcock; Claire ; et al. | 2009-08-27 |
| Organic Compounds App 20090048281 - Press; Neil John ; et al. | 2009-02-19 |
| Organic Compounds App 20080312322 - Baettig; Urs ; et al. | 2008-12-18 |
| Organic Compounds For the Treatment of Inflammatory or Allergic Conditions App 20080200466 - Axford; Jake ; et al. | 2008-08-21 |
| Organic compounds App 20060287362 - Collingwood; Stephen Paul ; et al. | 2006-12-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 